Lidoderm and Prostate cancer - a phase IV clinical study of FDA data

Summary:

Prostate cancer is reported as a side effect among people who take Lidoderm (lidocaine), especially for people who are 60+ old, also take Ms Contin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Prostate cancer when taking Lidoderm. It is created by eHealthMe based on reports of 10,321 people who have side effects when taking Lidoderm from the FDA, and is updated regularly.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

What is Prostate cancer?

Prostate cancer is found to be associated with 1,001 drugs and 1,202 conditions by eHealthMe. Check the latest studies of Prostate cancer.

On Jul, 08, 2026

10,321 people reported to have side effects when taking Lidoderm.
Among them, 43 people (0.42%) have Prostate cancer.

Among these 43 people:

What is the age of people who have Prostate cancer when taking Lidoderm? *

What are other drugs people take besides Lidoderm? *

What are other side effects people have besides Prostate cancer? *

Stress And Anxiety: 30 people, 69.77%
Fatigue (feeling of tiredness): 30 people, 69.77%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 25 people, 58.14%
Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 55.81%
Joint Pain: 23 people, 53.49%
Weakness: 22 people, 51.16%
Hypoaesthesia (reduced sense of touch or sensation): 21 people, 48.84%
Neck Pain: 21 people, 48.84%
Agitation (state of anxiety or nervous excitement): 20 people, 46.51%
Pain In Jaw: 20 people, 46.51%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 18 people, 41.86%
Multiple Myeloma (cancer of the plasma cells): 10 people, 23.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 9.30%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.65%
Movement - Uncoordinated: 2 people, 4.65%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 4.65%
Nausea (feeling of having an urge to vomit): 2 people, 4.65%
Muscle Spasms (muscle contraction): 2 people, 4.65%
Birth Control: 1 person, 2.33%
Bladder Transitional Cell Carcinoma Metastatic (types of bladder cancer-metastatic): 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lidoderm and have Prostate cancer?

- Check whether Prostate cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lidoderm:

Lidoderm (10,524 reports)

Prostate cancer treatments and more:

Prostate cancer (224,100 reports)

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prostate cancer:

Prostate cancer (1,001 drugs)

Browse all the conditions that are associated with Prostate cancer:

Prostate cancer (1,202 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine (the active ingredients of Lidoderm) and Lidoderm (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.